Ukucoceka okuphezulu kwe-10-DAB Semi-synthetic Paclitaxel

Inkcazelo emfutshane:

I-10-DAB i-semi-synthetic paclitaxel yi-compound efunyenwe nge-semi-synthesizing paclitaxel, kwaye idlala indima ebalulekileyo kwintsimi yezonyango.


Iinkcukacha zeMveliso

Iithegi zeMveliso

Ulwazi ngeMveliso

Igama:10-DAT Semi-synthetic Paclitaxel

Inombolo yeCAS:33069-62-4

Ifomula yemichiza:C47H51NO14

Iinkcukacha:99%-102%

Umbala:umgubo omhlophe okanye phantse omhlophe

Umthombo:Taxus yunnanensis,Taxus chinensis

Uhlobo:APIs

Imisebenzi ye-10-DAB semi-synthetic paclitaxel

1. Impembelelo ye-Anticancer: I-10-DAB inomsebenzi onamandla we-anticancer ofana ne-paclitaxel kwaye ingasetyenziselwa ukunyanga iintlobo ezahlukeneyo zomhlaza, kubandakanywa umhlaza wesifuba, umdlavuza we-ovari, umdlavuza wamaphaphu, njl.

2. Imathiriyeli ekrwada yamachiza e-chemotherapy: I-10-DAB isandulela esibalulekileyo sokuvelisa amachiza e-anticancer chemotherapy.I-Semi-synthesizing paclitaxel inokunyusa imveliso kunye nokunciphisa iindleko, ukwenza ukuba amachiza e-anticancer abe lula ukuvelisa kunye nokusetyenziswa kwinqanaba elikhulu.

3. Uphando lweziyobisi kunye nophuhliso: Indlela yokwenziwa ye-10-DAB nayo ibalulekile ekuphuhliseni amachiza amatsha e-anticancer.Abaphandi banokuqhubeka nokuphucula kwaye bayile iimolekyuli zamachiza ezisebenzayo nezikhethiweyo ezisekelwe kubume be-10-DAB.

Ngokubanzi, njengemveliso ye-semi-synthetic ye-paclitaxel, i-10-DAB inomsebenzi ofanayo we-anticancer kwaye idlala indima ebalulekileyo kwimveliso kunye nophando kunye nophuhliso lwamachiza e-anticancer.

Iinkonzo zethu

1.Iimveliso:Ukubonelela ngomgangatho ophezulu, izicatshulwa zezityalo ezisulungekileyo, imathiriyeli ekrwada yamayeza, kunye nabaphakathi bamayeza.

2.Iinkonzo zobugcisa:Izicatshulwa ezenziwe ngokwezifiso ezineenkcazo ezizodwa ngokweemfuno zabathengi.

Umzi-mveliso we-Hande

Yiba ngoyena mthengisi ubalaseleyo wezinto ezikrwada kunye namashishini anentembeko!

Wamkelekile ukuba uqhagamshelane nam ngokuthumela i-imeyile kumarketing@handebio.com


  • Ngaphambili:
  • Okulandelayo: